GCBC's joint liquidators sell full stake in Cordlife Group

They hold a 9.99% stake in the company.

The joint liquidators of Global Cord Blood Corporation (GCBC) have disposed of their entire stake in the Cordlife Group.

In a bourse filing, Cordlife reported that Margot Maclnnis and John Royale of Grant Thornton Specialist Services disposed of more than 25.5 million shares or 9.99 stake in the company.

Maclnnis, Royale, and Chow Tsz Nga are joint provisional liquidators of GCBC, making them deemed interested in the shares of Cordlife.

GCBC holds an interest in Cordlife through China Stem Cells (East) Company Limited (CSCECL), which owns 25.5 million shares in Cordlife. 

China Stem Cells Holdings Limited (CSCHL), for which GCBC is the sole shareholder, is also the sole shareholder of CSCECL.